132 related articles for article (PubMed ID: 21090376)
1. [Managing side effects of androgene deprivation in prostate cancer].
Thalgott M; Gschwend JE; Retz M
MMW Fortschr Med; 2010 Oct; 152(41):40-3. PubMed ID: 21090376
[No Abstract] [Full Text] [Related]
2. Should we follow-up serum testosterone in patients with advanced prostate cancer?
Perachino M
Expert Rev Anticancer Ther; 2010 Jul; 10(7):1031-5. PubMed ID: 20645692
[TBL] [Abstract][Full Text] [Related]
3. Castration refractory prostate cancer: cinderella finally comes to the ball.
Chowdhury S; Harper P; Powles T
Onkologie; 2010; 33(12):655-6. PubMed ID: 21124035
[No Abstract] [Full Text] [Related]
4. Hormonal treatment of prostate cancer.
Garnick MB
N Engl J Med; 1999 Mar; 340(10):812-3. PubMed ID: 10075531
[No Abstract] [Full Text] [Related]
5. Treating asymptomatic patients with hormone-refractory prostate cancer: hormonal manipulations for the urologist.
Boudreaux KJ; Chang SS
BJU Int; 2008 Mar; 101(6):671-4. PubMed ID: 18070172
[No Abstract] [Full Text] [Related]
6. [Complete hormonal block vs. simple hormonal block in the treatment of carcinoma of the prostate].
Berenguer Sánchez A
Arch Esp Urol; 2002 Sep; 55(7):771-5. PubMed ID: 12380304
[No Abstract] [Full Text] [Related]
7. Androgen deprivation therapy for prostate cancer.
Bahnson R
J Urol; 2007 Oct; 178(4 Pt 1):1148. PubMed ID: 17698142
[No Abstract] [Full Text] [Related]
8. Endocrine treatment of prostate cancer.
Tammela T
J Steroid Biochem Mol Biol; 2004 Nov; 92(4):287-95. PubMed ID: 15663992
[TBL] [Abstract][Full Text] [Related]
9. Editorial: hormone therapies for prostate cancer--acute disease control, chronic disease progression.
Lamb DJ; Buttyan R
J Urol; 2003 Apr; 169(4):1558. PubMed ID: 12629414
[No Abstract] [Full Text] [Related]
10. How should we understand the term androgen deprivation therapy?
Drewa T; Soloway MS
Eur Urol; 2012 Apr; 61(4):856. PubMed ID: 22266269
[No Abstract] [Full Text] [Related]
11. The androgen receptor for the radiation oncologist.
Quero L; Rozet F; Beuzeboc P; Hennequin C
Cancer Radiother; 2015 May; 19(3):220-7. PubMed ID: 25921704
[TBL] [Abstract][Full Text] [Related]
12. [Management of a hormone dependent cancer with endocrine therapy--prostate cancer].
Tsukamoto S; Akaza H
Gan To Kagaku Ryoho; 2001 Jul; 28(7):917-26. PubMed ID: 11478140
[TBL] [Abstract][Full Text] [Related]
13. The benefits of early androgen blockade.
Maroni PD; Crawford ED
Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):317-29. PubMed ID: 18471789
[TBL] [Abstract][Full Text] [Related]
14. [Diferelin treatment of primary local and generalized cancer of the prostate].
Kolesnikov GP; Rusakov IG; Shaplygin LV; Voznesenskiĭ SA; Bystrov AA
Urologiia; 2001; (6):17-9. PubMed ID: 11785073
[No Abstract] [Full Text] [Related]
15. Androgen deprivation in men with prostate cancer is associated with an increased rate of bone loss.
Preston DM; Torréns JI; Harding P; Howard RS; Duncan WE; McLeod DG
Prostate Cancer Prostatic Dis; 2002; 5(4):304-10. PubMed ID: 12627216
[TBL] [Abstract][Full Text] [Related]
16. Is there a role for pure antiandrogens in the treatment of advanced prostatic cancer?
Pavone-Macaluso M; Serretta V; Daricello G; Pavone C; Cacciatore M; Romano C; Cavallo N
Prog Clin Biol Res; 1990; 350():149-57. PubMed ID: 2201041
[TBL] [Abstract][Full Text] [Related]
17. The importance of pretreatment testosterone and other prognostic variables in the response to androgen deprivation therapy.
Soloway MS
Prog Clin Biol Res; 1990; 350():141-8. PubMed ID: 2201040
[No Abstract] [Full Text] [Related]
18. Residual androgen depending in hormone-resistant prostate cancer.
Fosså SD
Acta Oncol; 1997; 36(1):81-2. PubMed ID: 9090973
[No Abstract] [Full Text] [Related]
19. Early androgen deprivation for prostate cancer?
Eisenberger MA; Walsh PC
N Engl J Med; 1999 Dec; 341(24):1837-8. PubMed ID: 10588970
[No Abstract] [Full Text] [Related]
20. Educational tool-kit on diet and exercise: survey of prostate cancer patients about to receive androgen deprivation therapy.
Lebret T; Coloby P; Descotes JL; Droupy S; Geraud M; Tombal B
Urology; 2010 Dec; 76(6):1434-9. PubMed ID: 21130255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
